Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_000548.5(TSC2):c.2834A>C(p.Lys945Thr) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
Review Status: criteria provided, single submitter
Collection Method: clinical testing
The p.K945T variant (also known as c.2834A>C), located in coding exon 24 of the TSC2 gene, results from an A to C substitution at nucleotide position 2834. The lysine at codon 945 is replaced by threonine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Gain of phosphorylation at K945 (P = 0.0115);Gain of phosphorylation at K945 (P = 0.0115);Gain of phosphorylation at K945 (P = 0.0115);.;Gain of phosphorylation at K945 (P = 0.0115);Gain of phosphorylation at K945 (P = 0.0115);Gain of phosphorylation at K945 (P = 0.0115);Gain of phosphorylation at K945 (P = 0.0115);.;Gain of phosphorylation at K945 (P = 0.0115);Gain of phosphorylation at K945 (P = 0.0115);Gain of phosphorylation at K945 (P = 0.0115);Gain of phosphorylation at K945 (P = 0.0115);Gain of phosphorylation at K945 (P = 0.0115);.;